Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Finesse Solutions is a leading provider of scalable automation and control systems for the bioprocessing industry. The company's flagship product, the TruBio software platform, offers a unified environment for managing bioprocess data from laboratory scale to commercial production. Their portfolio includes high-performance single-use sensors and universal controllers designed to be compatible with a wide range of bioreactor systems. Acquired by Thermo Fisher Scientific in 2017, Finesse's technologies are integral to modernizing biomanufacturing workflows through improved data integrity and process efficiency. The company's solutions enable biopharmaceutical manufacturers to accelerate time-to-market and reduce operational costs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Finesse.